| 20.1141 0 (0%) | 09-28 09:46 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.76 | 1-year : | 24.04 |
| Resists | First : | 20.34 | Second : | 20.59 |
| Pivot price | 20.05  |
|||
| Supports | First : | 19.95 | Second : | 16.6 |
| MAs | MA(5) : | 20.08 |
MA(20) : | 20.11 |
| MA(100) : | 20 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.9 |
D(3) : | 26.8 |
| RSI | RSI(14): 49.3 |
|||
| 52-week | High : | 20.59 | Low : | 19.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MHIG ] has closed below upper band by 27.9%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 20.14 - 20.22 | 20.22 - 20.29 |
| Low: | 19.85 - 19.95 | 19.95 - 20.04 |
| Close: | 19.96 - 20.11 | 20.11 - 20.25 |
The Milliman Healthcare Inflation Guard ETF (MHIG) aims to counteract the rising expenditures in healthcare, distinct from general economic inflation, by utilizing proprietary actuarial data and sophisticated quantitative modeling. Its analytical foundation relies on Milliman's extensive collection of genuine healthcare claims, encompassing roughly 35 million insured individuals, to project future healthcare inflation through observed trends in medical and pharmacy costs. The fund's investments include a mix of equities and fixed-income securities spanning the entire healthcare supply chain, supplemented by instruments designed to hedge against inflation such as commodities, Treasury Inflation-Protected Securities (TIPS), and U.S. Treasury bonds. A quantitative model typically directs the fund's monthly rebalancing to adapt to changes in U.S. healthcare cost inflation. This strategy dynamically alters its asset allocation, increasing its focus on equities and commodities when inflation is elevated, and shifting towards debt instruments as inflationary pressures subside. The portfolio may also include various derivative instruments like swaps, options, and futures, in addition to exchange-traded funds (ETFs).
Wed, 10 Jun 2026
Watch: Captives offered hedge against healthcare inflation - Royal Gazette | Bermuda
Wed, 06 May 2026
ETF Prime: New Launches Surge Past 370 in 2026 - ETF Trends
Sun, 26 Apr 2026
Milliman Healthcare ETFs Target Rising Costs - 401k Specialist
Wed, 22 Apr 2026
Kintra Forms From Merger of 6 Wealth Management Firms - planadviser
Wed, 22 Apr 2026
If You Can't Beat Health Care Cost Increases ... Hedge Them? - ThinkAdvisor
Tue, 21 Apr 2026
Milliman touts ETFs targeting the rising cost of healthcare - investmentnews.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Bonds
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|